An artificial intelligence (AI) tool developed by Cedars-Sinai investigators accurately predicted who would develop pancreatic cancer based on what their CT scan images looked like years prior to being diagnosed with the disease. The findings, which may help prevent death through early detection of one of the most challenging cancers to treat, are published in the journal Cancer Biomarkers.
To commemorate a new art exhibit at Cedars-Sinai, Robert C. Davidson, Jr., vice chair of the Smithsonian Art Museum, will lead an April 27 virtual panel discussion called Open Doors: A Conversation on the Healing Power of Diversity in Art.
The 2022 Annual Report from the Smidt Heart Institute at Cedars-Sinai is available now, detailing the latest research and medical achievements by the expert team ranked No. 1 for cardiology and cardiac surgery in California by U.S. News & World Report.
This Donate Life Month, the Nettleton and Conklin families are celebrating nearly 16 years of being family.
Using advanced techniques for imaging the brain and eyes, along with new biomarkers, researchers in the Department of Neurology at Cedars-Sinai are working to present a clearer picture of multiple sclerosis (MS). Their work could lead to improved diagnosis and treatment of the disease, in which the body’s immune system attacks the brain, spinal cord and optic nerves.
Pregnant women continue to have reservations about getting vaccinated against COVID-19 despite research indicating the safety of the vaccines and the protection they may offer their unborn children.
Like many collegiate athletes, Dahlia Fink, 18, was introduced to sports at a young age.
Vesicles secreted from human heart cells may repair damaged tissue and prevent lethal heart rhythm disorders, according to a new study from investigators in the Smidt Heart Institute at Cedars-Sinai.
Physician-scientists from the Smidt Heart Institute at Cedars-Sinai are working to identify genetic risk factors for cardiomyopathy—a collection of conditions that reduce the heart’s ability to pump blood to the rest of the body—and how inherited forms of the condition can be detected at earlier stages.
Throughout the month of April—Donate Life Month—experts from Cedars-Sinai Comprehensive Transplant Center and the Smidt Heart Institute are available for interviews on issues related to transplantation, immunology and organ donation.
Cedars-Sinai Marina del Rey Hospital has received Primary Stroke Center designation from the Joint Commission—a nonprofit accrediting body for healthcare organizations and programs—and the American Stroke Association. The designation certifies the hospital’s readiness to provide evaluation and emergency care for stroke patients beyond what is available at the average hospital.
Every Thursday, a panel of clinicians from Cedars-Sinai gathers on a video call to spend a full hour talking about a single patient. Each week, the patient is different, but all have one thing in common: No doctor has been able to figure out exactly what ails them.
A new drug shows promise in providing relief to hypertrophic cardiomyopathy patients experiencing shortness of breath, according to late-breaking research presented today at the American College of Cardiology (ACC) Scientific Session in Washington, D.C.
The Los Angeles Barbershop Blood Pressure Study is delivering cutting-edge insights more than four years after the study results were published in The New England Journal of Medicine.
Michelle Kittleson, MD, PhD, Director of Post-Graduate Education in Heart Failure and Transplantation and Director of Heart Failure Research in the Smidt Heart Institute, Can Discuss New Clinical Guidance
Cedars-Sinai’s newest department, Computational Biomedicine, is up and running, giving the Cedars-Sinai Newsroom an opportunity to speak with the department’s founding chair, Jason H. Moore, about the history of this relatively new field, how to mine big data and the future of artificial intelligence in healthcare.
This tipsheet highlights the latest medical discoveries and faculty news at Cedars-Sinai. Links to full news releases are included with each tipsheet item.
Cedars-Sinai Cancer experts will present their latest advances in treatments and research at the American Association for Clinical Research (AACR) Annual Meeting 2022 in New Orleans, April 8-13. They will share their innovations to improve the quality of patient care.
Cedars-Sinai neurology experts are available to discuss the latest advances in research and clinical care for patients with disorders of the nervous system ahead of the 74th annual meeting of the American Academy of Neurology (AAN), happening April 2-7.
Clinician-scientists in the Smidt Heart Institute at Cedars-Sinai developed a clinical algorithm that, for the first time, distinguishes between treatable sudden cardiac arrest and untreatable forms of the condition.
Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and heart surgery programs, will present an array of innovative research data and lead discussions on medical breakthroughs during the American College of Cardiology (ACC) Annual Scientific Session & Expo, taking place in person and virtually April 2-4.
Adding an anti-inflammatory medication to immunotherapy and standard chemotherapy drugs may provide long-term suppression of aggressive bladder tumor growth, according to a proof-of-concept study led by Cedars-Sinai Cancer investigators.
Cedars-Sinai announced today a $10 million gift to establish the Bernard and Maxine Platzer Lynn Family Memory and Healthy Aging Program in the Department of Neurology. The program will broaden the scope of age-related care at Cedars-Sinai—with a focus on healthy aging, patient independence, care coordination, and brain health.
Investigators from Cedars-Sinai have created an artificial intelligence-enabled tool that may make it easier to predict if a person will have a heart attack.
Researchers have uncovered new information about how the area of the brain responsible for memory is triggered when the eyes come to rest on a face versus another object or image.
Cedars-Sinai orthopaedic experts will present their latest advances in treatments and research at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) in Chicago March 22-26, sharing innovations to improve the quality of patient care and diversify the ranks of surgeons.
As mask mandates disappear across the U.S., many are eager to return to pre-pandemic life. But scientists warn against letting down our guard too soon, pointing out that new variants could arise in the months ahead.
When Reverend Hannah Rhiza steers her Spiritual Care Cart through Cedars-Sinai Marina del Rey Hospital, it's hard not to notice. The tiered trolley for staff overflows with neat stacks of flavored teas and self-care notecards nestled among a lollipop topiary and flickering electric tea lights.
Investigators at Cedars-Sinai have identified a potential new therapy for COVID-19: a biologic substance created by reengineered human skin cells.
The brain is front and center during March, and experts from the Cedars-Sinai departments of Neurology & Neurosurgery are available for interviews about the latest research and treatments for neurological diseases and conditions, including multiple sclerosis, epilepsy and traumatic brain injuries.
Researchers have discovered two types of brain cells that play a key role in dividing continuous human experience into distinct segments that can be recalled later. The discovery provides new promise as a path toward development of novel treatments for memory disorders such as dementia and Alzheimer’s disease.
There are no ifs, ands or “butts” about it: March is Colorectal Cancer Awareness Month and a timely reminder to get screened for one of the deadliest—and most preventable—cancers.
Two years after the pandemic began, the virus that causes COVID-19 is becoming a little easier to live with, thanks to medical innovations.
Just a decade ago, patients with severe aortic stenosis—a narrowing of the heart’s main valve—were left with two options: undergo high-risk open-heart surgery or do nothing to treat their life-threatening condition.
Targeting a specific protein that is often overexpressed in prostate cancer can help prevent or delay the disease from spreading to other parts of the body, according to a study led by Cedars-Sinai Cancer investigators.
Kiranbir Josan, MD, a noninvasive clinical cardiologist, has joined the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai, ranked among the country’s best by U.S. News & World Report.
The highly contagious omicron variant of SARS-CoV-2 became the dominant strain in the United States in mid-December 2021, coinciding with a rise in hospitalizations of patients with COVID-19. Among those admitted during the omicron surge, vaccinated adults had less severe illness compared with unvaccinated adults and were less likely to land in intensive care, according to a new study by Cedars-Sinai and the Centers for Disease Control and Prevention (CDC).
Physician-scientists in the Smidt Heart Institute at Cedars-Sinai have created an artificial intelligence (AI) tool that can effectively identify and distinguish between two life-threatening heart conditions that are often easy to miss: hypertrophic cardiomyopathy and cardiac amyloidosis. The new findings were published in JAMA Cardiology.
Prominent gynecologic oncologist and surgeon B.J. Rimel, MD, recently was named medical director of the Cedars-Sinai Cancer Clinical Trials Office. She will serve as a medical liaison between clinical trial principal investigators and Cedars-Sinai Cancer leadership to ensure the quality of services provided to patients.
Cedars-Sinai has opened the Acoustic Neuroma and Lateral Skull Base Center, further expanding its expertise in treating patients with these noncancerous—but potentially life-altering—tumors.
Maxine Aubry, a paragon of health for most of her 81 years, was shocked by the back-to-back cancer diagnoses she received last summer - an aggressive cancer in her left breast in June, followed by a pancreatic cancer diagnosis.
Investigators at Cedars-Sinai have uncovered a new pathway that helps explain how consuming too much alcohol causes damage to the liver, specifically mitochondrial dysfunction in alcohol-associated liver disease. The discovery can also help lead to a new treatment approach for people suffering from the disease.
A new collection of scientific articles shines a light on the differences between men and women when it comes to heart health. Experts from the Smidt Heart Institute at Cedars-Sinai led the project, which resulted in an anthology of 14 scientific articles that review the past decade of research on women’s cardiovascular health.
Cancer treatments save lives. They also might cause heart damage in the process. Cedars-Sinai research scientist Arun Sharma, PhD, wants to be able to predict when this might happen, and is creating models of the human heart by using stem cells derived from blood. The goal is to better personalize cancer treatments.
This year marks the fourth anniversary of the affiliation between Cedars-Sinai and Torrance Memorial Medical Center, a partnership forged to bring greater coordination of leading-edge healthcare and services to patients throughout greater Los Angeles.
People in love often say two hearts beat as one, and the hearts of Tom and Therese Mazzei are definitely in sync. When 59-year-old Tom Mazzei traveled from Guam to the Smidt Heart Institute at Cedars-Sinai for treatment, Therese Mazzei, his wife of more than 30 years, accompanied him and found herself being examined for her own heart symptoms.
A new cloud-based data resource co-developed by scientists at Cedars-Sinai provides the research community with a comprehensive set of tools to help identify new subtypes of amyotrophic lateral sclerosis (ALS), a fatal neurological disorder.
As we come up on the two-year anniversary of the COVID-19 pandemic, nerves are fraying, stress levels are rising, and frustration is mounting everywhere. Healthcare workers say they often bear the brunt of people's anger, especially as the latest surge fills hospitals and doctors' offices once again.
Amid the uncertainty of the ongoing COVID-19 pandemic, the Cedars-Sinai Comprehensive Transplant Center and Smidt Heart Institute together completed 573 solid organ transplants in 2021, surpassing 2020’s count of 529 and achieving a new record for the medical center.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
